-+ 0.00%
-+ 0.00%
-+ 0.00%

Truist Securities Maintains Hold on Hims & Hers Health, Raises Price Target to $48

Benzinga·07/17/2025 14:39:25
Listen to the news
Truist Securities analyst Jailendra Singh maintains Hims & Hers Health (NYSE:HIMS) with a Hold and raises the price target from $45 to $48.